Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Has the U.K. Pharma Industry valuation changed over the past few years?
|Sun, 28 Nov 2021||UK£225.3b||UK£61.7b||UK£5.7b||30.3x|
|Tue, 26 Oct 2021||UK£230.5b||UK£58.2b||UK£7.5b||26.6x|
|Thu, 23 Sep 2021||UK£226.2b||UK£58.4b||UK£7.5b||28.9x|
|Sat, 21 Aug 2021||UK£232.7b||UK£58.1b||UK£7.5b||27.5x|
|Sat, 05 Jun 2021||UK£190.4b||UK£56.2b||UK£8.5b||26.8x|
|Tue, 09 Mar 2021||UK£166.1b||UK£57.2b||UK£8.3b||33.9x|
|Mon, 30 Nov 2020||UK£186.6b||UK£57.9b||UK£8.4b||41.7x|
|Thu, 03 Sep 2020||UK£198.1b||UK£59.5b||UK£8.5b||44.1x|
|Sun, 07 Jun 2020||UK£209.6b||UK£59.1b||UK£6.8b||22.2x|
|Sat, 29 Feb 2020||UK£178.4b||UK£55.7b||UK£6.0b||16.4x|
|Tue, 03 Dec 2019||UK£196.7b||UK£56.4b||UK£6.6b||18.4x|
|Fri, 06 Sep 2019||UK£108.4b||UK£21.8b||UK£2.1b||31.2x|
|Mon, 10 Jun 2019||UK£163.6b||UK£52.0b||UK£6.1b||33.5x|
|Sun, 03 Mar 2019||UK£162.8b||UK£51.7b||UK£5.6b||20.3x|
|Wed, 05 Dec 2018||UK£169.3b||UK£50.1b||UK£3.5b||37.8x|
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 28.8x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 18% per year over the last three years, and revenues for these companies have grown 7.2% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the U.K. Pharma industry?
Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 28.8x. This is likely because analysts are expecting annual earnings growth of 25%, which is higher than its past year's earnings decline of 21% per year.
Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 25% over the next 5 years. This is better than its past earnings decline of 21% per year.
ECO Animal Health Group